142 related articles for article (PubMed ID: 15971583)
21. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
Gauthier ER; Piché L; Lemieux G; Lemieux R
Cancer Res; 1996 Mar; 56(6):1451-6. PubMed ID: 8640839
[TBL] [Abstract][Full Text] [Related]
22. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.
Figueroa B; Chen S; Oyler GA; Hardwick JM; Betenbaugh MJ
Biotechnol Bioeng; 2004 Mar; 85(6):589-600. PubMed ID: 14966800
[TBL] [Abstract][Full Text] [Related]
23. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
[TBL] [Abstract][Full Text] [Related]
24. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
Vilenchik M; Raffo AJ; Benimetskaya L; Shames D; Stein CA
Cancer Res; 2002 Apr; 62(7):2175-83. PubMed ID: 11929841
[TBL] [Abstract][Full Text] [Related]
25. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
26. Part I. Bcl-2 and Bcl-x(L) limit apoptosis upon infection with alphavirus vectors.
Mastrangelo AJ; Hardwick JM; Bex F; Betenbaugh MJ
Biotechnol Bioeng; 2000 Mar; 67(5):544-54. PubMed ID: 10649229
[TBL] [Abstract][Full Text] [Related]
27. Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma.
Mohiuddin I; Cao X; Fang B; Nishizaki M; Smythe WR
Cancer Gene Ther; 2001 Aug; 8(8):547-54. PubMed ID: 11571532
[TBL] [Abstract][Full Text] [Related]
28. [Effect of phosphorothioate antisense Bcl-xL oligodeoxynucleotides on apoptosis and thermosensitivity of BcaCD885 cells].
He YW; Bian L; Liang XH
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):112-4. PubMed ID: 15190790
[TBL] [Abstract][Full Text] [Related]
29. Mercuric chloride-induced programmed cell death of a murine T cell hybridoma. I. Effect of the proto-oncogene Bcl-2.
Aten J; Prigent P; Poncet P; Blanpied C; Claessen N; Druet P; Hirsch F
Cell Immunol; 1995 Mar; 161(1):98-106. PubMed ID: 7867088
[TBL] [Abstract][Full Text] [Related]
30. Rubella virus-induced apoptosis varies among cell lines and is modulated by Bcl-XL and caspase inhibitors.
Duncan R; Muller J; Lee N; Esmaili A; Nakhasi HL
Virology; 1999 Mar; 255(1):117-28. PubMed ID: 10049827
[TBL] [Abstract][Full Text] [Related]
31. Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway.
Chen GG; Liang NC; Lee JF; Chan UP; Wang SH; Leung BC; Leung KL
Apoptosis; 2004 Sep; 9(5):619-27. PubMed ID: 15314290
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma.
Memon SA; Moreno MB; Petrak D; Zacharchuk CM
J Immunol; 1995 Nov; 155(10):4644-52. PubMed ID: 7594463
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
Moreno MB; Memon SA; Zacharchuk CM
J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
[TBL] [Abstract][Full Text] [Related]
34. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.
Schmitt E; Cimoli G; Steyaert A; Bertrand R
Exp Cell Res; 1998 Apr; 240(1):107-21. PubMed ID: 9570926
[TBL] [Abstract][Full Text] [Related]
35. Expression and role of Bcl-xL in human hepatocellular carcinomas.
Takehara T; Liu X; Fujimoto J; Friedman SL; Takahashi H
Hepatology; 2001 Jul; 34(1):55-61. PubMed ID: 11431734
[TBL] [Abstract][Full Text] [Related]
36. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
[TBL] [Abstract][Full Text] [Related]
37. Glycosylation of an immunoglobulin produced from a murine hybridoma cell line: the effect of culture mode and the anti-apoptotic gene, bcl-2.
Majid FA; Butler M; Al-Rubeai M
Biotechnol Bioeng; 2007 May; 97(1):156-69. PubMed ID: 17013932
[TBL] [Abstract][Full Text] [Related]
38. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
Liu QY; Stein CA
Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595
[TBL] [Abstract][Full Text] [Related]
39. Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression.
Saito H; Ebinuma H; Takahashi M; Kaneko F; Wakabayashi K; Nakamura M; Ishii H
Hepatology; 1998 May; 27(5):1233-40. PubMed ID: 9581676
[TBL] [Abstract][Full Text] [Related]
40. Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.
Luo D; Cheng SC; Xie H; Xie Y
Biochem Cell Biol; 2000; 78(2):119-26. PubMed ID: 10874473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
